https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-07-01 12:57:562016-11-28 12:58:17SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen® Versus Supportive Care in Patients With Myelodysplastic Syndromes
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-06-09 12:59:312016-11-28 12:59:55Astex Announces New Drug Discovery Alliance with Janssen Pharmaceutica N.V.
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-05-28 13:00:052016-11-28 13:00:29Astex Drug Candidates to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-04-22 13:01:122016-11-28 13:01:33SuperGen to Webcast 3rd Annual Analyst Day on April 29, 2008
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-04-22 12:01:422016-11-28 13:02:09Royal Society of Chemistry recognises Astex Scientists
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2008-04-16 13:02:202016-11-28 13:02:44SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, that Causes Tumor Regression in AML Xenograft Models
